Trisha Patel, MD
Dermatology · Santa Fe, NMNPI 1053731927
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.9%), consulting fees and education — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Medtronic at 39.8% of the total. Reporting peaked in 2024 at $970 and has fallen 72.9% since, to $263 in 2025.
Across 70 payments — averaging $36.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- AbbVie$218
- LEO Pharma Inc.$217
- Regeneron Healthcare Solutions, Inc.$132
- Novartis$115
- Amgen$109
- plus $755 from 25 others
What the payments were for
- Consulting fees$1,02040%
- Food & beverage$1,51259%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $1,020 |
| AbbVie | 6 | $218 |
| LEO Pharma Inc. | 10 | $217 |
| Regeneron Healthcare Solutions, Inc. | 6 | $132 |
| Novartis | 6 | $115 |
| Amgen | 5 | $109 |
| Bristol Myers Squibb | 3 | $65 |
| Genentech USA, Inc. | 3 | $65 |
| Exelixis Inc. | 3 | $60 |
| UCB, Inc. | 2 | $59 |
| Sanofi | 3 | $50 |
| AstraZeneca | 1 | $35 |
| Vertex | 1 | $32 |
| Merck | 1 | $30 |
| Johnson & Johnson | 1 | $29 |
| Tempus AI, Inc | 1 | $27 |
| Genmab U.S., Inc. | 1 | $25 |
| Karyopharm Therapeutics Inc. | 1 | $25 |
| DUSA Pharmaceuticals, Inc. | 1 | $24 |
| Bayer | 1 | $23 |
| Avanos Medical | 1 | $22 |
| VYNE Pharmaceuticals Inc. | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Next Science LLC | 1 | $21 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $19 |
| Incyte Corporation | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Taiho Oncology, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Stryker | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,566 in reported general payments places this provider in the 65th percentile of 52 dermatology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 96 | $5,900 |
| Clobetasol Propionate | 93 | $3,652 |
| Tacrolimus | 14 | $1,479 |
| Triamcinolone Acetonide | 116 | $1,448 |
| Ketoconazole | 82 | $1,119 |
| Imiquimod | 13 | $750 |
| Metronidazole | 12 | $681 |
| Clindamycin Phosphate | 27 | $504 |
| Tretinoin | 15 | $485 |
| Doxycycline Hyclate | 23 | $408 |
| Gentamicin Sulfate | 14 | $366 |
| Mupirocin | 40 | $332 |
| Hydroxyzine Hcl | 30 | $212 |
| Nystatin | 13 | $135 |
| Cephalexin | 15 | $86 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Santa Fe
- John BowdenSanta Fe$3K
- Allison LeglerSanta Fe$2K
- James AuerbachSanta Fe$446
- Brenda SchneiderSanta Fe$236
- Ronald RovnerSanta Fe$192
- Diane ReisingerSanta Fe$0
- Andrew OndoLas Cruces$215K
- John DurkinAlbuquerque$153K
- Barbara EinhornAlbuquerque$15K
- Carol PurcellAlbuquerque$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.